Public-private partnership alternative for a national pharmacare program in Canada.
Eric NauenbergEmre YurgaPublished in: Journal of pharmaceutical policy and practice (2023)
We show that universal coverage is still possible while leveraging the existing system of private extended health insurance so long as a well-established system for coordinating benefits between public and private payers is established. A stable public/private partnership can achieve universal coverage so long as a system for coordinating benefits is instituted. The proposed alternative will achieve the same goals, but maintain a niche for the private sector thereby maintaining therapeutic variety in the marketplace.